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cys'rro FIBROSIS-ITS GZm~TICS, THE HETEROZYGOUS STATE AIm ITS DETECTION 
In 1912, Garrod and rrurtley described two children born to first 
cousins parents, who, in retrospect, probably suffered from cystic 
fibrosis. This description also suggested recessive inheritance of an 
'inborn error of metabolis~1 in the pancreas. Oystic fibrosis is described 
as a generalized disease of exocrine glands, having its onset in the new-
born period, infancy or early childhood. It manifests itself clinically 
by the follo\.ring: 1. Loss or diminution of pancreatic exocrine secretions. 
2. By increased susceptibility to upper respiratory infections, and 
pneumonia resulting in the pathologic changes of bronchietasis, atelec-
taslS and emphysema. ,. Elevation of sodium and chloride concentration 
in sweat gland secretions. l 
Meconi,~ ileus, a type of intestinal obstruction, was formerly 
attributed to a complete absence of pancreatic enzymes, however, more 
recently it has been demonstrated that the inspissation of meconium is 
primarily due to abnormal intestinal mucoid secretions rather than pan-
creatic achlia. Meconiu~ ileus is present in 15% of all newborns who will 
.,., 
be affected with cystic fibrosis.'::' It is the earliest and most severe 
manifestation of ti1is disease in the newborn infant. The ai':f'ected infant 
vii thout meconium ileus who appears normal at birth, f'ails to thrive satis-
factorily even though he may have an increased apoetite. This deficiency 
of pancreatic digestion results in bulky, unformed, foul smelling stools 
in both infants with or 1.>1i thout meconium ileus. 
The respiratory manifestations present initially as a severe non-
productive cough, which later becomes spasmociic and productive. The 
dysfvnction of~the mucus-producing glands of the respiratory tree results 
in the formation of thick tenacious mucus within the trachea and bronchi. 
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This abnormal secretion hinders normal ciliary movement in the bronchi, 
plugs the smaller bronchioles and encourages bacterial invasion of the 
lungs) 
The analysis of sweat for its sodium or chloride content has become 
the most reliable laboratory method for confirming the diagnosis of cystic 
fibrosis. The level of sodium chloride in the sweat of a cystic fibrotic 
patient is consistently fOD,r to i'ive times higher than in normal controls 
in the pediatric age group. No other disease, except adrenal insuffi-
ciency, can cause such a marked elevation of' salt in the sweat. Use 
of this sweat assay for studying various groups of adults has revealed 
that a moderate percentage of heterozygote carriers of the cystic 
fibrosis gene (parents 01' cystic f'ibrotic patients) also manifest a 
slight moderate elevation of sweat electrolyte. Such studies have also 
suggested that certain adults vii th chronic bronchial disease, peptic ulcer 
or even diabetes mellitus, may have mild forms of cystic fibrosis. These 
cases of' cystic fibrosis could possibly be detected by finding; an ele-
vation in sweat electrolyte, but this concept has not been universally 
accepted. Interpretation of' electrolytes in the carrier, have been 
clouded by an apparent increase in svfeat electroljrte level with age. it 
So, the final diagnosis of cystic f'ibrosis is usually based on 
the clinical signs noted in preVious paragraphs and laborator;t f'indings 
of the a.1eat sodium. and chloride excretion, absent trypsin activity in 
pancreatic secretions from duodenal fluid obtained by intubation or tJ~­
ice1 pancreatic changes at autopsy. 
Although cystic fibrosis is almost undoubtedly a disorder of exo-
crine gland function, the moleculer basis for the disease is not known. 
But in the great majority of' those recessive condi tiona in 'i."lhich the 
biochemical defect has been elucidated this has proven to be a reduction 
in the activity of' a specific enzyme. In most instances the effect of 
the mutation is I'm amino acid substitution in the enzyme. Such changes 
can result in a complete loss of enzyme activity, as \':fell as reduced or 
altered activity. In other recessive disorders, it appears that there 
is a complete loss of any protein production as a result of the gene 
mutation. The possibilities for the enzymatic defect in cystic fibrosis 
are: a base change which results in a nonsense code; a mutation in an 
operator or regu.lator gene, or even a small chromosome deletion. Mutations 
,;,hich are thought to produce a change in a structural protein, such as 
collagen, are usually dominant. It is therefore, perhaps more likely 
the defect in cystic fibrosis will be found to be an enzymatic defect, 
rather than a primary defect in the peptide part of a glyco-protein. 2 
The familial nature of cystic fibrosis was first described in 1946.5 
A few years later it was generally concluded that the inheritance 
pattern could be best explained on the basis of an autosomal recessive 
gene. Although some groups have attempted to establish a possible link-
age betT.-leen cystic fibrosis, wi til such remote associations as blood groups 
and many other lin.lcages, there is now almost total agreement with the 
single alltosomal gene theory. 
Cystic fibrosis results from the presence of' two pathologic auto-
somal recessive genes in an indiVidual. In order to produce a recessive 
homozygote eacc, normal parent must cS.rry a pathologic cystic fibrotic gene. 
Each parent must also have a normal gene at the cystic fibrosis locus. 
other individuals who do not hs.ve the pathologic gene illOuld possess two 
dominant normal alleles at the cystic fibrosis locus. 
Three types of individuals with respect to the cystic :fibrosis gene 
.. ~. 
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are thus present in the population, normal with both dominant alleles; 
carrier with one normal allele and one cystic fibrosis gene; and those 
afTected with t'l'IO pathologic cystic £,i 1:>rosis genes. Presently carriers 
can be detected only through the production of aff'ected children. Almost 
all af'fected children are produced by carrier pe,rents, since affected 
persens (homozygotes) with cystic fibrosis rarely live to reproduce. 
Carrier parents can produce three types of children: norr:lal 1;'i'ho 
have received only normal cystic fibrosis alleles, carrier or hetero-
zygote \'11ho have received a normal allele from one parent and a pathologic 
cystic fibrosis from the other parent; and a:t"'fected individuals who he,ve 
received a pathologic cystic fibrosis gene from each parent. Oarrier 
parents are capable of producing these three type::;, of' offspring in the 
ratio of' 1:2:1. Thus, each child produced by such parents has one chance 
in four of being either completely normal or of being affected, and one 
chance in twe of being a carrier. These chance phenomena do not change 
from one pregnancy to the next, no matter what genotype the previous off-
spring have been, the next child has the same genetic potentialities as 
all of the siblings. 
Because of the rarity of carriers in the general population, it is 
unusual that t,yO carriers will marry and produce affected children. 
Oarriers are much more likely to occur in kindreds of' affected cases than 
in the general population. Because of the familial aggregation of the 
carrier state, there is a high incidence of' consanguinity in the recessive 
disease, that is, a carrier is much znore likely to marry another carrier 
if the person were related, t~lan if he were not.l 
Overall prevalence of the condition is not informative because of 
great mortality in infancy and early childhood. This mortality in part, 
is based on the assl.:mption that of those presenting with meconium ileus 
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only about one case in three has survived until age five. Ranges of 
rlOspital reports, often with referrals, is about 1 in 600, this is 
probably an unduly high estimate. The best range worldHide seems to be 
between 1 in 1,000 and 1 in 10,000, as determined by various researches. 
Confirmed by most studies the incidence in the United States is closer 
to 1 in 2,500. The incidence of 1 in 2,500 implies a gene frequency 
of about 1 in 50 in these popu1ations,since cousin marriage rate is 
low, and a heterozygote frequency of about 1 in 25. This disease is 
rare both in Negro and Mongolian populations. 
If one accepts the figure of 1 in 2,500 and a mortality of two 
out of taree by the age of:fti:e, this means the.t this single condi tioD 
is responsible for between one and two percent of all deaths under age 
of five. The incidence of the condition in children of surviving pa-
tients will give a direct estimate of gene frequency.7,11,12 
If' the incidence of cystic fibrosis is essentially determined by 
the mutation rate and hitherto there was a tIigg,mortality in childhood, 
the mutation rate must be of the order of 1 in 2,500. This is (iuite 
exceptionally high for a gene mutation rate and so heterozygote advan-
tage is suggested. The selective advantage in the case of cystic fibro-
sis needs to be relatively small, an increase in fitness of only about 
2% of heterozygotes over individuals homozygous for the normal gene. 
Such a heterozygote advantage will only operate in high incidence areas, 
and so a clue may ,.'ell come, as it did with sickle cell anemia and 
malaria from geographical surveys of the incidence of the disease. 
It is, of course, possible that the heterozygote advantage no 
longer exists. Where malaria has been eliminated there is probably 
no longer any extra fitness of' heterozygotes for the sickle cell gene 
but the high frequency \<{ilLremain in ¥.est Africa for centuries to 
come. 
Many attempts to demonstrate a heterozygote advantage in cystic 
fibrosis have been made, but no definite conclusions concerning the 
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resul ts have been reached. Using the }remise that there is an advant-
age to the carrier which would result in increased fertility, has been 
examined, in light of knowledge accumulating in the literature regarding 
changes in mucus and electrolyte secretions in the reproductive tract 
during the normal ovulatory cycle. Attention has been given to detect-
ing any differences that may exist between carrier cases and normal 
individuals regarding these secretions, in the hope that this might 
contribute kno>vledge to the underlying defect in cystic fibrosis. 
Evidence of heterozygote advantage, secondary to increased 
fertility, was sought by studying the size of families of grandparents 
of' patients wi tn cystic fibrosis. Despite the great care taken in .:,' 
matching three different control couples with each grandparental pair, 
considerable variation existed between the three series of controls. 
In only one of the control groups does the i'a'TIily size differ sig-
nii'icantb from that of the fibrocystic family and even in this in-
stance a possible explanation is suggested. However, in a1~! the 
comparisons made, the fibrocystic disease grandpc.rents had the larger 
families. 'fhese results >'lere presented with great reservations about 
their biological significs.nce; end with the realization that the 
magnitude of the heterozygote advantage apparently shown is very much 
greater than "V'lould be needed to maintain the gene at a steady fre~uency 
in the cu~~~nity. 
If one uses the data describinG larger family size in i.letero-
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zygotes an explanation of greater fertility is needed. This could op-
era.te in two ,\fays, firstly, fertilization could be more ef£'icient; 
secondly, embedding of OVcl!!l and Tl1aintenance of pregnancy could be more 
efficient. Secretions in the female genital tract and their relation-
ship to fertility is not completely kno'dn, but it. is thought that the 
increa:s;e in sodium chloride in cervical mucu;:; pea}::s at the time of 
ovulation. The cervical ~ucus at this time becomes less viscous and 
8h01'18 spinnbarkiet. This seems to favor sperm passage. This raises 
the possibility that the heterozygote may possess a. better Tucus-salt 
relationship at ovulation for a lon>,:er time before and after ovula-
Q 0 10 +.; ~n v, /' i 
V.J;..U • 
.~ 
'I'he difficulties raised by the high incidence of cystic fibrosis 
"ii/auld be much less if homozygosity for several different autosomal 
genes could cause cystic fibrosis. Congential deafness for example, 
may probably be caused by up to six different autosomal recessive genes 
as well as being caused in several other ways, beth genetic and envi-
r011rnental. HOiiever, 1.n c;;rstic fibrosis the incidence in cousins with 
affected children and also the low parental:::onsanguinity rate in 
Caucasian populations indicates that only one gene locus is mainly 
involved. If the gene frequency is 1 in 50, the proportion of first 
cousins affected should be about 1 in 200, which it has been found to 
be. There may well be, no\vever, rare variants of the disease due to 
mutations similar to but not identical with that causing the common 
form of' the disease. 
If the affected sibs or patients, whose disease is mild and of 
late onset also tend to 11.ave a form of the disease whicCl is mild and 
of late onset, one might have to assume that another mutant gene other 
than the usual gene is involved, perhaps another mutant at the same locus. 
8 
G~ten two or three mutant genes may cause conditions which are very 
similar clinically. 
Dr. O. O. carterl~.xmmarizies the need for further research into 
the gtmetics ai' cystic fibrosis as follo,{ls: 1. Surveys, preferably 
prospecti ve, of' the incidence in tlle many areas of the \vorld for 1,vhich 
figures are not yet available. ( A screening test in the nel~born l'Tould 
be most valuable here.) 2. Determination oftthe relative parental 
consanguinity rate in areas of low incidence of the disease. 5. The 
detection of heterozygotes which may have to wait, for the determination 
of the basic biochemical anomaly. 4. The determination of the selec-
tive advantage of heterozygotes in the areas of high incidence. 5. The 
prevention of the disease in the incidence areas will have to came by 
tCle routine detection of the 4;~ of children ';°iho are heterozygotes and 
,'!arning them against marrying each other. 
No clinical anomalies have been definitely shown to occur unduly 
orten in those known to be heterozygous for the mutant gene, for ex-
ample parents of children ''''ith cystic f'ihrosis. Olaims to demonstrate 
a variety of pulmonary and gastro-intestinal disorders in heterozygotes 
have not been conf'irmed. Most studies show that such parents had no 
~m'Jal!-':I1ent in respiratory functions. The small increase in sweat 
sodium and chloride in adults with chronic respiratory disease, if it 
exists at all, is no reason for suggesting that they are heterozygotes 
for the gene of cystic fibrosis. The problem is to find what the extra 
fitness of heterozygotes for cystic fibrosis is due and any substantial 
proneness to disease in heterozygotes is difficult to reconcile with 
the incidence of the disease. If such disease proneness exists, it 
~vould i,nply an even greater fitness in other respects. It is conceivable 
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that a minor degree of up.i'i tness in hetero~rgotes in adult life might 
be compensated by increased fitness in childhood, but this is improbable. 
The general rule with autosomal recessive conditions, is that it 
is not possible to pick up tho.3e heterozygous for the mutant gene until 
t:Ie direct effect of the gene mutation, at least in terms of the enzy-
matic activity of the protein product of the gene, has been found. This 
is in contrast with the X-linked conmtions in which, because of the 
inactivation of one of the X chromsomes, it is often possible to pick 
up female heterozygous for mutant genes by relatively crude clinical 
tests.l4 
The idea of being able to detect the heterozygous state is the key 
to the success in the driYe to decrease the incidence of cystic fibrosis. 
Even with the expert medical care given at various University centers 
for cystic fibrosis the death rate remains high. The survival time is 
being lengthened gradua.lly and mild cases are living into adulthood, but 
tne basic defect of the disease remains unknown as does the cure. So, 
at present, t:1e only hope for cure is to find the etiology of the dis-
ea.se and hopefully correct the defect. But the surest and easiest 
mett,od of controlling the disease, lies in the prevention of the disease. 
This could be accomplished by being able to detect the carrier state 
and thus "Iarn carriers of the consequences \qhich could result from 
their mating with another oarrier. Most of the new and exciting re-
search in cystic fibrosis is now being directed toward the goal of being 
able to detect the heterozygote and thus prevent the diseas,,;_ 
The first area explored in the detection of the carrier state was 
an evalution of the idea that the heterozygote might have an increased 
sodi,)1l1 cl1loride in sweat as is noted in the patients with cystic fibrosis. 
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Mvl tiple factors are known to affect the concentration of s8_1 t in 
The rate of sweat secretion, skin t~nperature, salt intake, 
adrenal function, acclimation to heart, snd the region of the body 
from which the sweat is obtained, are all known to affect its chloride 
concentration. The choice of drug used to stimulate sweating and the 
analytical met~od used in the assay can also affect the chloride value 
obtained. Thus it is difficult to compare different surveys reported 
in the literature, making it imperative for each laboratory to deter-
mine its o-.,.m normal range of sweat chloride value by their Oim technique. 
It is not surprising to find a binodal population of normal adults 
since it is noW accepted that a percentage of known heterozygotes have 
a moderate elevation of sweat chloride. There must be an even greater 
number of u~~~own heterozygotes in the 'normal' population than there 
are known heterozygotes who have by chance mated "Ii th another heter-
ozygote and given birth to a child with cystic fibrosis. One can only 
speculate regarding the possibility that nermal adults with slightly 
elevated S'i'Tes.t chloride are heterozygous i'or cystic fibrosis, since 
there is not as yet any truly diagnostic tests to perform in an asys-
tematic indiVidual. Long term observation of such individuals may be 
rev,arding in the pulmonary problems which may develop in such individ-
uals with increased frequency. 
Most data from parents of cystic fibrosis patients indicate there 
is an increase incidence of elevated chloride levels in the sweat of 
these individuals. The mean chloride value for this groups was signif-
icantly higher than normal controls. The percentage of individuals with 
s,veat chloride values over 40 meq/l. is signli'icantly higher for the 
parents of cystic fibrosis children compared to th.e normals. 
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Normal siblings of cystic fibrosis patients did not show any great 
deviation from normal children in this regard, but if the trend of the 
normal data is correct, a greater number of these siblings ma.y develop 
higl1er sweat chloride values as they reach adulthood, resulting in a 
true rise of mean chloride values ~1i th age in this group_ 
It was noted in one study concerning the sweat electrolytes in 
carriers, that in most instances it is not possible to diagnose heter-
ozygosity for cystic fibrosis, with any degree of certainty, on the 
basis of a single S\'leat chloride concentration determination. This is 
attributed to the fact that the distribution of single values in normal 
i2:1:ldivi~.m:ti in known heterozygotes overlap by 70 to 805:b. However, 
the fact still remains that the distribution of the sweat chloride values 
is higher in knOltffl heterozygotes does suggest that the recessive gene 
is expressed to some extend. 
One may :~,ostu18te that the heterozygctes nsve two popUlations of 
sweat secreting units, normal and affected, each independently dis-
tribuy.ed on the skin, and each having its Olm characteristic mean and 
distribution. A total pooled bod:! sw"eat test ,\-lQuld yield a sweat chloride 
value '(,hieh was a mean of both populations of the secreting units and 
,fould be a function of the :nean of each population and the relative 
freqvency of each, the latter being conditioned by ti'J.e expressivi ty 
of the recessi va gene. Those heterozygctes id th affected genes of low 
expressivity might fall within the range of normal S'.'leet chloride values. 
'rne value obtained by weighted patch collection is a sample mean 
of a number of secreting units. And sample means have a ncnaal distri-
bution around the true mean. The chloride value of' sweat collected f'rom 
a simple patch, then depends on: 1. The l:lJ.eans of normal 8.nd ai'fected 
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secreting unit populations. The expressivity of' the affected gene. 
3. The relative f*re~u_ency o~ normal and affected units sampled by the 
particular patch collection. By performing multiple patch collections 
on different 8i tes on 8_n individual, the mean and varianc e of the set 
of sample means can be determined. In a homozygous normal individual, 
the mean of the sample s~t will be low and the variance small, since 
the secreting unit are from only one population. In the heterozygote, 
the mean of the samples may be normal or elevated, depending on the two 
popula.tions means and gene expressivi ty, but the variance will be large, 
since the population is a double one. 
So it was proposed that using bot~l the mean and variance of a set 
of sweat tests on an individual, it might be possible to distinguish 
between homozygous normal individuals and carriers of the disease. The 
problem of aSSigning an unknown individual, such as a sibling of' a child 
~li th cystic fibrosis to either normal or carrier population on the basis 
of these t~To variables is one of' discriminating ana1vsis. 15 -" .. 
The results using the discriminate analysis technique sho1'led 8ll7~ 
of the parents and 8,1~ of the genetically expected number of siblings 
were identificalDle as heterozygotes. Thus, 16% of the parents and 17% 
of the sibling who fall in the normal zone represent heterozygotes of 
very low expressivity. These may change zones to a diagnostically 
significant extent on repeat testing. 
It is conceivable that under appropriate stress, as applied in 
determinmsthe carrier of phenylketonuria, the remaining parents and 
sibling could be i'ound to differ in some respect from the control 
group. 'the fact that some heterozygotes are detectable in cystic fibro-
sis lends weight to ti:1e theory that even a so-called recessive gene has 
_________ ._6_"'rJ'¥_"'''' __ ''''·~---~~-· _" ______________ _ 
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some expression in the heterozygous state. One type of stressful sit-
uation tried in order to bring out the hidden heterozygote >vas a salt 
deprivation test.16 
It is known that norma.l individuals depleted of salt will produce 
sweat of low electrolyte concentration because of the salt conserving 
influence of aldosterone. Children with cystic fibrosis, however, under 
the same conditions, continue to produce salt of high electrolyte con-
centration in spite of normal levels of' aldosterone. It was thought 
then, that perhaps the heterozygote carriers of the cystic fibrosis gene 
when subjected to similar conditions of salt deprivation, might be unable 
to conserve sa.! t in the same way as that shovln by the aff'ected children. 
This conjecture became the basis of a study, to subject kno\Yn carriersl: 
to a low sodium chloride diet in hopes it might unmask the recessive 
disorder. But the results ,;'ere unproductive as there was a decrease 
in Svleat chloride values of similar magnitude in both parents of cystic 
fibrosis patients and controls as the diet continu:ed. It "JaS concluded 
that the stu.dy of sweat electrolyte levels in salt deprived su.bjects 
is of no value in the diagnOSis of cystic fibrosis heterozygotes. 
It can be concluded from the studies of sweat chloride levels in 
adul ts and children, that a Svleat chloride assay is an excellent and 
simple procedure for confirming a diagnosis of cystic fibrosis in a 
child or young adult. A normal chloride level should strongly suggest 
that the patient probably does not have cystic fibrosis and that an-
other diagnosis should be made. In adults, the test has only limited 
usef'ulness for detecting heterozygotes or carriers of the cystic fibrosis 
gene, although kno'tIn heterozygotes and adults with chronic lung disease 
were found to have an increased incidence of individuals with slight to 
moderate elevation of sweat chloride. In addition most data suggests 
that the normal adult population is a dual population in regard to the 
level of' chloride in sweat, leaving room for much speculation regarding 
the significance and meaning of' the higher chloride group. Evidence 
was obtained suggesting that the high chloride normal group appears 
on~y in adulthood, and that these individuals may have had lower sweat 
chloride values during childhood. 
The normal range of' chlorides values in adults has not conclusively 
been deCided, but a.ny value above 40 meo/I. sho-dld probably be viewed 
i'li th suspicion. This inexact upper limit of normal does not affect 
the use of' the assay as a test of cystic fibrosis, in as much as the 
cnare.cteristic sweat chloride in homozygous is in an extreme range that 
does not appear to overlap the values found in the remaining population. 
So at this time the main value of the sweat chloride assay is for the 
d' . -, th ' t' .p" ,17,18 ~agnos~s oI ".e nomozygous cys ~c J.~oros~s. 
Another type of study was undertaken in hopes that the minor 
labial salivary glands would reveal changes that would be used to dis-
tingl.lish not only patients with cystiC fibrOSis from nonnal patients, 
bU.t also patients heterozygous i'or the gene for cystic fibrosis from 
normal patients. 19 Af'ter intensive studies only one characteristic 
of cystic fibrosis stood out, plugs of a smooth, eosinophilic material 
ir. the lumen of some acini. The presence of these eosinophilic plugs 
was.the criterion used to designate that a minor labial submaXillary 
or parotid salivary gland was abnonaal. 
The criterion abnormality, acinar plug of eosinophilic material, 
was confinned to be present in over 8070 of' children ,'lith cystic fibrosis. 
The abnormality was rS.re in children undeY 20 years of age who did not 
have cystic fibrosis. The abnorm8.1i ty beC2<Ille rela;'"tively more f'requent 
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in both adult groups, parents of children with cystic fibrosis and 
normal controls, as the age of the groups increased. This type of 
tasting of the labial minor salivary glands could be obtained with 
a minimum of trauma, so that studies could be easily done on heal ti:-.y 
persons to see if criterion could be found peculiar to the heterozygote 
carrier of the gene for cystic fibrosis. The impression that parents 
of cnildren with cystic f'ibrosis show the cri te'rion abnormality in 
tae mucous salivary glands at an earlier age than do normal adults 
is strong, but cannot be proved from the presented data. The results 
may indicate an accelerated rate of change in carriers caused by a 
basic glandular defect which normally occur slowly over many years o 
(~ the other hand, the changes may be entirely~~specific and could 
soley be due to morphcil.ogicexpressicn of the gland when subject to 
stress or injury. So in conclUSion, these changes appear earlier and 
more frequently and significantly more severely in adults who are 
known heterozygous for cystic fibrosis, ~~t this criterion cannot be 
used as the sole bases to identify the heterozygous. These observations 
mainly suggest that factors are operating in patients \'1i th cystic 
fibrosis which affect certain tissues or their secretions in sll.ch a 
\vay that ci1anges occur in childhood vlhich would ordinarily not be seen 
until later in adult life. 
Cme of the most promiSing studies in the i'ield of cystic fibrosis 
. ,. 'd' D AS .20 ~s oe~ng carr~e on oy r .. ,pOCK. His group is studing the effect 
of sera from patients with cystic fibrosis upon human and animal respira-
tory trect epithelium. First observations indicated that these sera 
produced an asymmetrical cilia.ry beat. The study \'las designed to elu-
cidate the significance of' this abnorulal beat and to detect factors 1·11 th-
in the sera of ~atients with cytic fibrosis responsible for the beat, 
snd possibly help clarify the pathogenesis snd genetics of' cystic 
:eibrosis. 
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It has been snO,'l1n that ciliary ;11Otili ty is essential f'or main-
temince of' proper respiratory function by constantly moving the mucus 
blanket of the respiratory tract upward to\-Iard the oral cavity. AI-
though it has not been ?roven that ciliary motility is impa.ired in 
patients with cystic fibrosi~, these individuals do show damage to 
cilia and changes in the volume and consistency of the mucus which re-
duce effective transport and result in bronchial obstruction with pul-
mona.ry dysfunction. 
The nature of the study \-ras in vitro, the serum from a patient 
with cystic fibrosis was ap"Dlied to a tissue specimen, rabbit tracheal 
epi thelium. An asymmetrical beat ,,/as observed wi thin fi va to ten min-
utes and perSisted ror a period up to one hour. Ai'ter this time the 
border became obscured \)'i th desquamated cells:_and vIas no longer suitable 
for study. The degree of altered activity was unrelated to the age of 
the patient, severity of the disease, or sweat chloride level. In 
contrast, sera from all of the control patients produced no ~tl terations 
in the ciliary beat in a similar time period. 
By. bioassay"techhique the fraction in the sera of these patients 
"thich was reponsible ror the asymmetrical beat ''las identif'ied. The 
major component was found to reside in the euglobulin, lvater-insoluble 
fraction. To determine whether the abnorma_l serum rae tor was also pre-
sent in heterozygotes, sera from some of the parents of the patients 
used in the study were tested. The sera from 28% of the parents 'Ylas 
capable of alternating the ciliary rhythm. In further testing, the 
remainer o:f' the parents \'/hose '1hole sera failed to produce an asymmet-
trical best, euglobulin (lvster in-solulbe) fraction was prepared and 
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examined. \1i th a concentrated euglobulin fraction produced, en asymmet-
rical beat 1::1 all these parents vlaS noted. 1:!hereas, the ell.globulin frac-
tion prepared in a similar mannt9r from the sera of an equal number of 
ad"ult volunteers with no family history of cystic fibrosis was positive 
in only one case. This one subject had a normal sweat chloride test. 
The presence of this unique protein in the serum is significant 
in vie",! of the identification of mucoprotein in bog,y fluids of cystic 
fibrosis patients by other investigators. Dische, initially observed 
the presence of' abnormal mucoprotein in duodenal fluid. !'1ucoprotein 
complexes have subsequently been described in sweat, submaxillary saliva, 
in urine and most recently in the feces. At uresent no direct corre-
lation has been made between the protein fraction which has been found 
in the sera and the mucoprotein noted by these other \>1orkers in body 
secr.eticns of patients with cystic fibnosis. 
The findings of a seru~ factor as well as the abnormal protein 
found in the urine, suggests that the suspected enzJ~atic defect in 
cystic fibrosis may not be limited to the exocrine glands. The abil-
ity of cystic fibrosis sera to cause an asymmetrical beat in cilia of 
respiratory tract epithelium obtained from s_nimals and humans initially 
led to postulation that the asy~etrical beat could be responsible for 
the retention of mucus by cystic fibrosis patients. This abnormality 
of ciliary function could potentiat~ ti16 effect of the viscid secre-
tions seen in this disease. It should be emphasized that the in vitro 
effect renorted above has not been seen in vivo. Examination of nasal 
polyps from patients with cystic fibrosis immediately upon removal show 
normal ciliary motility. 
Dr. Spock1s group is currently desi~ing experiments to improve 
purification and identification of the serum protein by various inununo-
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chemical techniques. It is hoped that this will enable them to determine 
the nature of' the protein and its constituents. This information 'tlill 
provide a more rapid and simnler assav technioue and perhans a 'Oossible 
- ""..I. ~ - ... .!. ... 
clue to the pathogenesis of cystic fibrosis. 
Another attempt to detect heterozygotes is being carried on by 
Danes and co-workers. 2l Initially this work has looked ve~J promising. 
Skin fibroblast cultures were used as the means of' detecting the cystic 
fibrosis patient and the heterozygous ca1'rier,a8 they showed easily rec-
ognizable cytoplasmic intravesicular metachromasia. The existence of 
a cellular abnO!'lilali ty recognizable in the fibroblasts of' these individ-
ual offers an experimental oPF'Ortuni ty to study tb.e primary defect of 
this common inherited disease at the molecular level. 
In this study, skin biopsies were obtained from the cystic fibro-
- sis patients, their parents, t1eal thy control s and persons ilit.::l miscel-
laneous illnesses. The cystic fibrosis patients all were diagnosed 
poei tive by abnormal l:\\;ieat tests. Monolayer skin fibroblast cultures 
were established by tissue culture procedures whicn were then stained 
and examined. Final resu.l ts snol-led subeulrt:.ures from heal thy unrelated 
individuals and patients v1i th a variety of other disease contained an 
occasionEtl cell sl:10wing metachrcmatic i~\clusions. \'fbile cultures de-
rived from the patients with cystic fibrosis contained large numbers 
of fibroblast showing evident cytoplasmic metachromasia. The metachro-
ma1iic material appeared to be contained w'i thin vacuoles or vesicles and 
"18S not distributed evenly throughout the cytoplasma. The size and 
shape of the inclusions "Jere not uniform and they were often restricted 
to one cytoplasmic area wi thin the cell. The proportion of cell s con-
taining metachromatic inclusions i:..1creased for apprOXimately two months 
after the establisllment of the monolayers snd then remained constant. 
-----------, -----, 
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Although the proportion of metachromatic cells did not vary signicantly 
after the fifth subculture, the number or vesicles per cell continued 
to increase. 
Fibroblast cultures derived from clinically unaffected carrier 
parents contained cells with metachromatic material similar to that 
seen in skin fibroblast obtained from their affected children. The 
time sequence for the appearance of metachromasia was similar to that 
seen in cultures from the affected individuals. Although there was 
some variation in the percent of metachromatic cells in the heterozyr;ous 
carriers, as well as the number of inclusions per cell, multiple biopsy 
specimens from the same area from a single individual sno\'led only slight 
variation. Cytopathic effects including vacuole formation and cyto-
plasmic granulation have been noted in human cell cultures as a result 
of mycoplasma infection. A considerable effort was made to determine 
i'ihether there was any relationship bet"leen the appearance of cytoplas-
mic vesicles and the infection of cultures with mycoplasma. No corre-
lation betv.reen the presence of mycoplasma and cytoplasmic vesicles was 
evident. Since mycoplasma infection was randomly present in the cul-
tures here, the possibility that it was responsible for the cytoplas-
mic vesicles in the positive cases is highly unlikely. 
Several genetic disorders can be investigated in cultured £'ibro-
blasts. The 8.ddi tion of cystic :f'i ')rosis to this list is noteworthy, 
since both clinice-l and chemical stu:dies have suggested that cystic 
!~ibrosis is an exocrine abnormality rather than a multicellul&r dis-
order involving connective tissues. The detection of a recognizable 
cell marker in both the affected 8nd carrier states provides an in 
vitro model for investigation of the primary molecular abnormality in 
this disease. 
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The metachromatic appearance of' the cultured cells derived :Crom 
pa tients "Ii th cystic fibrosis dif:Cers from that observed in the muco-
polysaccaridoses in which the metachromatic granules are more evenly 
distributed thro'~:ghout the cytoplasm. The striking variation in the 
degree of cellular metachromasia in cultures derived :Crcm both aff'ected 
indi vidual s and known carriers is similar to that seen in cell cultures 
established from the autosomal recessive mucopolysaccharidoses. As in 
the mucopolysaccharidoses, there seems to be correlation between the 
severi ty of t:'1e clinical disease, the number of metstchromatic cells or 
the number of inclusions per cell in the cultured skin fibroblast. 
Despite intensive clinical and laboratory investigations extending 
over many years, the primary inherited de:Cect in cystic fibrosis remains 
unknown. The glycoprotein-rich secretions w~~ch are produced in ex-
e essi ve t;t,mounts in cystic_~ fi br.osis do !;lot seem to di:Cfer 'luaIi tati vely 
f'rom those i'ound in healthy individuals. Findings indicate that skin 
fibroblasts, derived from affected individuals and carriers grown in 
cell cultures, contain characteristic metachromatic inclusions which 
may reflect the primary inherited defect in this disease. The c~em­
ical nature of' the metachromasia material has not yet been elucidated. 
It is noteworthy that carbohydrate containing proteins have not been 
:Cound to give strong metachromasia. An increase in sulfate groups 
attE'-Ched to the carbohydrate containing protein, may be responsible :Cor 
the staining reaction. 
In this series all the known carries shol'red cel1ular metachroma.sia, 
and the results with unknown carriers were compatible with th~ estimated 
carrier frequency of approximately 2 to 8 per cent. So, the approach 
tl.ere seems to provide a simple method to identify heal thy carriers, and 
affords a tool for det~rmini~directly the carrier frequency of this 
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highly lethal gene in the healthy population. Additional family 
studies will be required before the reliability of cell marker for 
detecting carriers can be established. The possibility that the appli-
cation of this technique will reveal genetic heterogeneity in cystic 
fibrosis can also be entertained. The recognition of a cellular ab-
normality in cultured fibroblast permits a more direct investigation 
of the molecular basis for this inherited disease, •. 
The latest effort to detect the cystic fibrosis heterozygote 
has been reported by J.VI. Balfe and associates. 22 Their motivation 
for this study stemmed from the work of Mangos and l~CSherry in , .. hlch 
they de-monstrated that the sweat from patients with cystic fibrosis 
inhibits sodium transport in the duct system of the rat parotid gland. 
This latest study examines the compotents of active transport in an-
other cell membrane system, the erythrocytes of patients with cystic 
fibrosis and their parents. 
Balfe's study shows that the mean concentration of sodium per liter 
of red blood cel~ for affected and the control group was very similar. 
The sodium efflux studies were then done with erythrocytes from pa-
tients with cystic fibrosis and parents of patients each of these 
studies were coupled with a control. 
THO sodium pumps were described: 1. Pump I is that component 
of sodium efflux which is inhibited by the addition of ouabain to a 
medium which contains sodium and potassium. 2. Pllll1P II is another 
decrement in the efflux of sodium which is due to the addition of 
ethacrynic acid to a medium which contains maximally inhibi te.ble con-
centrations of ouabain. The remnant of' the efflux, that is, the CCID-
panet of the total ef'flux unaccounted for b;! pumps I and II is referr-
ed to as the "leak". This presumably correlates with the permeability 
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of the red blood cell membrane. 
After data. for normals was compiled, patients with cystic f'ibro-
sis were studied under identical circumstances. Results showed the 
mean decrease in pump I is 15% of' control values. Pump II differences 
were even more strikingly decreased in patients with cystic fibrosis 
as pu~II was only 53% as active as their controls. These differences 
i'lere statistically significant. The "leak" parameter \WS statistically 
significantly less in the patients as well. 
So, patients with cystic fibrosis have a normal concentration of 
sodhun in red blood cells, but a diminished active efflux of sodium. 
This suggests that the passive influx of sodium, the "leak l! parameter, 
might possibly be diminished, and the "1eakll parameter of sodium efflux 
measured lid th isotopes is diminished. 
In erythrocytes from parents of these patients, there waS no 
difference in pump I nor in the associated ouabain sensitive ATP ac-
tivity, but there was a 56% dimi~J.tion in pump II. The magnitude of 
the depression in the acitivitv of pUlllP II is similar to that seen in 
,. ~ .1, .. 
the patients ~'1i th cystic fibrosis. 
The final conclusion of this investigation demonstrates a di-
mini shed active transport of' sodium in the erythrocytes of patients 
\>[i th cystic fibrosis. Of special significance is the marked decrease 
in that 'I'lhich is defined as pump II in the parents. This o.iJantitative 
marker of the heterozygous carrier of' the disease rna:' be useful in 
genetic st~ldies and in genetic counseling. 
In s-(~mmary the follo\-;ing may be concluded about the carrier of 
cystic fibrosis and its detection. No consistent clinical abnormalities 
have been found in these individuals. Studies of parents of patients 
"\'\[i th cystic fibrosis have shovlll no increased prevalence of respiratory 
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and gastrointestinal disease. The mean sw·eat sodium concentration 
and the sodium content of nails are frequently increased in km:n'f"n os.r-
riers, unfortunately, the heterozygous values overlap thosefound in 
normal individuals, and so these tests are unsuitable for the detec-
tion of carriers. The most promising studies in the area of cystic 
fibrosis detection are: (1) 'l'ne bioassay technique reported by Spock 
and cO-1rlorkers in 1967, 20this test is based on the observe.tion that 
sere. of carriers cause a dyskinesis of ciliary motility of rabbit 
tracheal cells in vitro. (2) The detection of metachromasia in fi-
broblast of carriers of cystic fibrosis by Dr. Danes and associates. 2i 
0) The detection of a red blood cell transport defect of patients 
with cystic fibrosis and in trleir parents. This investige.tion of J.W. 
Bul:te and co~orkers,2~ives a quantitative marker of the heterozygous 
carriers of cystic fibrosis. 
Vii th ftl.rther research and modifications of present data it seems 
reasonable that soon there will be a practical and simple means to de-
tect tIle 2-8% of the population thet are carriers for the cystic fibro-
sis gene. This type of testing would be of special value to high risk 
groups, such as sibs of affected patients and related married couples, 
as well as in the general population. If the information of being a 
carrier were made available to newly married couples good genetic 
counseling eQuId be provided. The risks involved of' having affected 
children could be explained.to these couples. Then each of the carrier 
couples could decide for themselves with the aid of genetic counseling 
if they Nould want to have children or not. So, theoretically this 
:night be the solution to end cystic :t'ibrosis simply with its prevention. 
Of course, the incidence would never be reduced to a zero level but with 
the kno\vledge of known carriers it seems likely the incidence rate can 
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be reduced to a lower level than the present estimated incidence of 
1 in 2,500 live births. With the continued ingenious research in 
cystic fibrosis and the ever present effort in the area of carrier 
detection, there remains hope that the molecular basis ox" the disease 
will be discovered. And with this information available a correction 
of the defect might be possible. 2" 24, 15 
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